A strong exonic splicing enhancer in dystrophin exon 19 achieve proper splicing without an upstream polypyrimidine tract

Journal of Biochemistry

Volumn 143, Issue 3, 2008, Pages 303-310

  Habara, Yasuaki ^a   Doshita, Mari ^b   Hirozawa, Sadako ^b   Yokono, Yuka ^b   Yagi, Mariko ^a   Takeshima, Yasuhiro ^a   Matsuo, Masafumi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Acceptor site sequences; Dystrophin; Exonic splicing enhancer; Polypyrimidine tract; Splicing

Indexed keywords

DYSTROPHIN; POLYPYRIMIDINE TRACT BINDING PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; EXON; GENE SEQUENCE; HELA CELL; HUMAN; PROTEIN ANALYSIS;

ALTERNATIVE SPLICING; BASE SEQUENCE; CELL EXTRACTS; CELL NUCLEUS; DYSTROPHIN; ENHANCER ELEMENTS (GENETICS); EXONS; GENES, REPORTER; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; POLYRIBONUCLEOTIDES; RNA SPLICE SITES; SEQUENCE ANALYSIS, DNA; TRANSFECTION;

EID: 40549119129     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvm227     Document Type: Article

References (25)

1. Matsuo, M. (1996) Duchenne/Becker muscular dystrophy: from molecular diagnosis to gene therapy. Brain Dev. 18, 167-172
2. Matsuo, M., Masumura, T., Nishio, H., Nakajima, T., Kitoh, Y., Takumi, T., Koga, J., and Nakamura, H. (1991) Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy Kobe. J. Clin. Invest. 87, 2127-2131
3. Blencowe, B.J. (2000) Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem. Sci. 25, 106-110
4. Graveley, B.R. (2000) Sorting out the complexity of SR protein functions. RNA 6, 1197-1211
5. Takeshima, Y., Wada, H., Yagi, M., Ishikawa, Y., Minami, R., Nakamura, H., and Matsuo, M. (2001) Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient. Brain Dev. 23, 788-790
6. Takeshima, Y., Nishio, H., Sakamoto, H., Nakamura, H., and Matsuo, M. (1995) Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe. J. Clin. Invest. 95, 515-520
7. Tian, M. and Maniatis, T. (1994) A splicing enhancer exhibits both constitutive and regulated activities. Genes Dev. 8, 1703-1712
8. Shapiro, M.B. and Senapathy, P. (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 15, 7155-7174
9. Sironi, M., Pozzoli, U., Cagliani, R., Comi, G.P., Bardoni, A., and Bresolin, N. (2001) Analysis of splicing parameters in the dystrophin gene: relevance for physiological and pathogenetic splicing mechanisms. Hum. Genet. 109, 73-84
10. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA
11. Kramer, A. (1996) The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu. Rev. Biochem. 65, 367-409
12. Burge, C.B., Tuschl, T., and Sharp, P.A. (1999) Splicing of precursors to mRNAs by the spliceosomes. in The RNA World (Gesteland, R.F., Chek, T.R., and Atkins, J.F., eds.) 2nd edn. pp. 525-560, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA
13. Roscigno, R.F., Weiner, M., and Garcia-Blanco, M.A. (1993) A mutational analysis of the polypyrimidine tract of introns. Effects of sequence differences in pyrimidine tracts on splicing. J. Biol. Chem. 268, 11222-11229
14. Coolidge, C.J., Seely, R.J., and Patton, J.G. (1997) Functional analysis of the polypyrimidine tract in premRNA splicing. Nucleic Acids Res. 25, 888-896
15. Zhuang, Y.A., Goldstein, A.M., and Weiner, A.M. (1989) UACUAAC is the preferred branch site for mammalian mRNA splicing. Proc. Natl. Acad. Sci. USA 86, 2752-2756
16. Tanaka, K., Watakabe, A., and Shimura, Y. (1994) Polypurine sequences within a downstream exon function as a splicing enhancer. Mol. Cell. Biol. 14, 1347-1354
17. Hoshijima, K., Inoue, K., Higuchi, I., Sakamoto, H., and Shimura, Y. (1991) Control of doublesex alternative splicing by transformer and transformer-2 in Drosophila. Science 252, 833-836
18. Wang, Z., Hoffmann, H.M., and Grabowski, P.J. (1995) Intrinsic U2AF binding is modulated by exon enhancer signals in parallel with changes in splicing activity. RNA 1, 21-35
19. Graveley, B.R., Hertel, K.J., and Maniatis, T. (2001) The role of U2AF35 and U2AF65 in enhancer-dependent splicing. RNA 7, 806-818
20. Fairbrother, W.G., Yeh, R.-F., Sharp, P.A., and Burge, C.B. (2002) Predictive identification of exonic splicing enhancers in human genes. Science 297, 1007-1013
21. Buratti, E., Baralle, M., and Baralle, F.E. (2006) Defective splicing, disease and therapy: searching for master checkpoints in exon definition. Nucleic Acids Res. 34, 3494-3510
22. Aartsma-Rus, A., Bremmer-Bout, M., Janson, A.A.M., den Dunnen, J.T., van Ommen, G.-J.B., and van Deutekom, J.C.T. (2002) Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy. Neuromusc. Disord. 12, S71-S77
23. McClorey, G., Fletcher, S., and Wilton, S. (2005) Splicing intervention for Duchenne muscular dystrophy. Curr. Opin. Pharmacol. 5, 529-534
24. Aartsma-Rus, A., De Winter, C.L., Janson, A.A.M., Kaman, W.E., Van Ommen, G.-J.B., Den Dunnen, J.T., and Van Deutekom, J.C.T. (2005) Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: indication for steric hindrance of SR protein binding sites. Oligonucleotides 15, 284-297
25. Takeshima, Y., Yagi, M., Wada, H., Ishibashi, K., Nishiyama, A., Kakumoto, M., Sakaeda, T., Saura, R., Okumura, K., and Matsuo, M. (2006) Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy. Pediatr. Res. 59, 690-694